CoChat

Serum levels of osteoprotegerin increase with age in a healthy adult population.

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Regulation of the balance of osteoblastic and osteoclastic activity is critical for the understanding of normal cell biology and forms the basis of metabolic bone diseases. Our study reports about influences of age and gender on serum levels of osteoprotegerin (OPG) and its association to other clinical parameters of bone metabolism in a precisely determined cohort of 1134 healthy subjects at 17 Austrian outpatient bone clinics, aged between 19 and 96 years (females n = 687, 50 +/- 21 years, 19-94, and males n = 447, 52 +/- 13.5 years, 24-96). Mean OPG serum levels for all participants were 50.83 +/- 51.47 pg/ml (n = 1134; median 36, 2-584) and we observed a sharp increase in females after 60 years and in males after 70 years of age. OPG serum levels increased significantly by age, 2.1 pg/ml in females and 1.9 pg/ml in males for every year (P < 0.0001). Correlation of OPG serum levels and several bone parameters of bone metabolism showed that OPG negatively correlated with serum iPTH (r = -0.14; P < 0.001) and with serum estradiol in females (r = -0.16, P < 0.0001). Bone mineral density measured by DXA method at the spine and at the hip did not correlate with OPG serum levels, except a borderline negative correlation at the trochanteric region (r = -0.1, P < 0.05) in females only. Our results show a significant increase of osteoprotegerin with age in healthy females and males but fluctuations do not predict bone mineral density under in vivo conditions.

Overview

Integrity signals

Registry

Crossref · 10.1016/s8756-3282(03)00090-5

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 4

  1. Simonet, 1997, Osteoprotegerin, Cell, 89, 309, 10.1016/s0092-8674(00)80209-3 · DOI · Paper page
  2. Kudlacek, 2000, DEXA at the lumbar spine and the hip in an unselected Austrian population, J Bone Miner Res, 15, S237
  3. Kotake, 1998, Presence of osteoclast inhibitory factor/osteoprotegerin in synofial fluids from patients with rheumatoid arthritis, Arthritis Rheum, 41, 1727
  4. Arrighi, 1998, Osteoprotegerin serum levels in healthy volunteers, Bone, 23, S298

Cited by

See all 203

Metadata

Authors
Kudlacek, S., Schneider, B., Woloszczuk, W., Pietschmann, P., & Willvonseder, R.
Affiliations
  • Ludwig Boltzmann Institute for Age Research (AT)
  • University of Vienna (AT)
Corresponding author
Kudlacek, S
Venue
Bone
Publisher
Elsevier BV
Published
2003-06
Volume
32
Issue
6
Pages
681-686
ISSN
  • 1873-2763 (ISSN-L)
  • 8756-3282
OpenAlex
W2091669661
Cited by
187
References
25
Citations by year
2026: 6 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 5 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 9 · 2015: 3 · 2014: 6 · 2013: 8 · 2012: 11
FWCI
5.63
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Bone (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
osteoprotegerin, aging, bone metabolism, bone mineral density, parathyroid hormone, estradiol, sex differences, healthy adults, bone remodeling
MeSH terms
Adult, Aged, Aged, 80 and over, Aging, Female, Glycoproteins, Humans, Male, Middle Aged, Population Surveillance, Regression Analysis, Sex Characteristics, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Statistics, Nonparametric, Osteoprotegerin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum levels of osteoprotegerin increase with age in a healthy adult population. https://app.cochat.ai/papers/10.1016/s8756-3282(03)00090-5
The paper
Kudlacek, S., Schneider, B., Woloszczuk, W., Pietschmann, P., & Willvonseder, R. (2003). Serum levels of osteoprotegerin increase with age in a healthy adult population. Bone. https://doi.org/10.1016/s8756-3282(03)00090-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.